1,052 results on '"Hui, David S."'
Search Results
2. Association of nirmatrelvir–ritonavir with post-acute sequelae and mortality in patients admitted to hospital with COVID-19: a retrospective cohort study
3. Keeping global focus on the many challenges of respiratory tract infections
4. Baseline gut microbiota and metabolome predict durable immunogenicity to SARS-CoV-2 vaccines
5. Perspectives on development and advancement of new tuberculosis vaccines
6. Real-world COVID-19 vaccine effectiveness against the Omicron BA.2 variant in a SARS-CoV-2 infection-naive population
7. Risk of air and surface contamination during application of different noninvasive respiratory support for patients with COVID-19
8. Author Correction: Real-world COVID-19 vaccine effectiveness against the Omicron BA.2 variant in a SARS-CoV-2 infection-naive population
9. Omicron BA.1-specific T-cell responses in adults vaccinated with CoronaVac or BNT162b2 in Hong Kong: an observational cohort study
10. Middle East respiratory syndrome coronavirus—a 10-year (2012-2022) global analysis of human and camel infections, genomic sequences, lineages, and geographical origins
11. Cross‐Reactive Antibody Responses to Coronaviruses Elicited by SARS‐CoV‐2 Infection or Vaccination
12. Influenza
13. Combining baloxavir marboxil with standard-of-care neuraminidase inhibitor in patients hospitalised with severe influenza (FLAGSTONE): a randomised, parallel-group, double-blind, placebo-controlled, superiority trial
14. Neutralizing antibodies against the SARS-CoV-2 Omicron variant BA.1 following homologous and heterologous CoronaVac or BNT162b2 vaccination
15. Multi-kingdom gut microbiota analyses define COVID-19 severity and post-acute COVID-19 syndrome
16. Trajectory patterns of SARS-CoV-2 neutralising antibody response in convalescent COVID-19 patients
17. Priming conditions shape breadth of neutralizing antibody responses to sarbecoviruses
18. SARS-CoV-2 accessory proteins reveal distinct serological signatures in children
19. Avian ‘Bird’ Flu – undue media panic or genuine concern for pandemic potential requiring global preparedness action?
20. A living WHO guideline on drugs for covid-19
21. Human Coronavirus Infections—Severe Acute Respiratory Syndrome (SARS), Middle East Respiratory Syndrome (MERS), and SARS-CoV-2
22. Historical perspective: other human coronavirus infectious diseases, SARS and MERS
23. Early Metabolomic and Immunologic Biomarkers as Prognostic Indicators for COVID-19.
24. Temporal trends in rates of infection-related hospitalisations in Hong Kong people with and without diabetes, 2001–2016: a retrospective study
25. De ja vu? Post-COVID-19 Surge in Respiratory Illnesses Among Children in China Emphasizes Need for Proactive Surveillance, Openness, Early Detection and Reporting of Causative Pathogen(s), and Their AMR Status
26. A 5‐year perspective on coronavirus diseases 2019 (COVID‐19).
27. Neutralizing antibody titres in SARS-CoV-2 infections
28. SARS-CoV-2 specific T cell responses are lower in children and increase with age and time after infection
29. Impact of interprofessional service-learning on the effectiveness of knowledge transfer of antimicrobial resistance to Hong Kong elders: a quasi-experiment
30. Temporal landscape of human gut RNA and DNA virome in SARS-CoV-2 infection and severity
31. High-flow nasal cannula for acute hypoxemic respiratory failure in patients with COVID-19: systematic reviews of effectiveness and its risks of aerosolization, dispersion, and infection transmission
32. Inferring Incidence of Unreported SARS-CoV-2 Infections Using Seroprevalence of Open Reading Frame 8 Antigen, Hong Kong.
33. Author Correction: Real-world COVID-19 vaccine effectiveness against the Omicron BA.2 variant in a SARS-CoV-2 infection-naive population
34. Lack of neutralizing antibodies against influenza A viruses in adults during the 2022/2023 winter season – a serological study using retrospective samples collected in Hong Kong
35. Middle East respiratory syndrome coronavirus: risk factors and determinants of primary, household, and nosocomial transmission
36. Characterization of upper airway microbiome across severity of COVID-19 during hospitalization and treatment
37. End of the Bedaquiline patent – a crucial development for moving forward affordable drugs, diagnostics, and vaccines for infectious diseases in low- and middle-income countries
38. Use of point-of-care biomarkers to reduce antibiotic resistance
39. Risk of air and surface contamination during application of different non-invasive respiratory support for patients with COVID-19
40. Obstructive Sleep Apnea, Obesity, and Noninvasive Ventilation: Considerations During the COVID-19 Pandemic
41. Effects of early corticosteroid treatment on plasma SARS-associated Coronavirus RNA concentrations in adult patients
42. Global mass gathering events and deaths due to crowd surge, stampedes, crush and physical injuries – Lessons from the Seoul Halloween and other disasters
43. Lack of neutralizing antibodies against the current circulating influenza viruses during the Omicron outbreak in Hong Kong
44. Pneumomediastinum and subcutaneous emphysema complicating a patient with a lung abscess
45. The Qatar FIFA World Cup 2022 and camel pageant championships increase risk of MERS-CoV transmission and global spread
46. Noninvasive Ventilation in Patients with Severe Acute Respiratory Syndrome
47. Noninvasive Mechanical Ventilation: Models to Assess Air and Particle Dispersion
48. Author Correction: A randomized controlled trial of an ambulatory approach versus the hospital-based approach in managing suspected obstructive sleep apnea syndrome
49. Use of Berlin questionnaire in comparison to polysomnography and home sleep study in patients with obstructive sleep apnea
50. Hybrid immunity and strategies for COVID-19 vaccination
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.